Vitamin K-Antagonist: An Illegal Means to Terminate Pregnancy?

被引:0
|
作者
Cupisti, S. [1 ]
Cupisti, D. [1 ]
Schwarze, B.
Ringwald, J. [2 ]
Schroth, M. [3 ]
Beckmann, M. W. [1 ]
Goecke, T. W. [1 ]
机构
[1] Univ Klinikums Erlangen, Frauenklin, Erlangen, Germany
[2] Transfus Med Univ Erlangen, Erlangen, Germany
[3] Univ Erlangen Nurnberg, Kinder & Jugendklin, Erlangen, Germany
关键词
vitamin K-antagonist; termination of pregnancy; 218; ANTICOAGULATION;
D O I
10.1055/s-0030-1250676
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Introduction: In Germany the number of terminations of pregnancies including not officially reported terminations is estimated to run to more than 200000 annually. Both surgical procedures and medications are used to legally terminate pregnancies. It is assumed that these procedures are also used for illegal terminations. Historically, the use of many different procedures has been reported. To date, however, therewere no reports of the illegal use of other ordinary medications to terminate pregnancy. Methods: Severe intoxication with a vitamin K-antagonist during pregnancy has been reported in two cases. The current legal and historical means of terminating pregnancy and the associated complications are presented here. Results: After excluding other reasons it must be assumed that in both cases either the pregnant patient herself or another person was responsible for the intoxication with the aim of terminating the pregnancy. In view of the historical precedents, intoxication with a vitamin K-antagonist with the intention of terminating a pregnancy appears to offer a new illegal means of termination, using a medication developed for a completely different purpose and which may, moreover, result in many complications. Conclusion: Physicians should be aware of this possibility as a rare differential diagnosis in special cases.
引用
收藏
页码:38 / 43
页数:6
相关论文
共 50 条
  • [31] Commentary on variability in vitamin K antagonist metabolism
    Smith, Dennis A.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2006, 2 (01) : 1 - 2
  • [32] Haematoma expansion and vitamin K antagonist reversal
    Zemrak, Wesley R.
    Smith, Kathryn E.
    Gagnon, David J.
    Rolfe, Stephen S.
    Seder, David B.
    LANCET NEUROLOGY, 2016, 15 (11): : 1116 - 1117
  • [33] Risk factors of vitamin K antagonist overcoagulation
    Marie, I.
    Leprince, P.
    Menard, J. -F.
    Tharasse, C.
    Levesque, H.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2012, 105 (01) : 53 - 62
  • [34] Switching from a vitamin K antagonist to a NOAC
    Senoo, Keitaro
    Lip, Gregory Y. H.
    LANCET HAEMATOLOGY, 2015, 2 (04): : E132 - E133
  • [36] New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint
    Rubboli, Andrea
    Agewall, Stefan
    Huber, Kurt
    Lip, Gregory Y. H.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 196 : 133 - 138
  • [37] A Pilot Study of Monotherapy with a Non-Vitamin K-Antagonist Oral Anticoagulant following Watchman Left Atrial Appendage Closure in Patients with Non-Valvular Atrial Fibrillation
    Price, Matthew J.
    Lerner, David
    Rastogi, Ashish
    Romero, Steven
    Smith, Michael R.
    Rubenson, David
    Funk, Jessica
    Janzcyk, Gwen
    Edwards-Mobley, Monique
    Wheeler, Carmen
    Gibson, Douglas
    STRUCTURAL HEART-THE JOURNAL OF THE HEART TEAM, 2020, 4 (04): : 288 - 292
  • [38] EPILEPSY IN PREGNANCY Vitamin K is important for epilepsy in pregnancy
    Divers, Mike
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 354
  • [39] Pros and Cons of Vitamin K Antagonists and Non-Vitamin K Antagonist Oral Anticoagulants
    Riva, Nicoletta
    Ageno, Walter
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2015, 41 (02): : 178 - 187
  • [40] Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial Fibrillation
    Patti, Giuseppe
    Pecen, Ladislav
    Lucerna, Markus
    Huber, Kurt
    Rohla, Miklos
    Renda, Giulia
    Siller-Matula, Jolanta
    Ricci, Fabrizio
    Kirchhof, Paulus
    De Caterina, Raffaele
    AMERICAN JOURNAL OF MEDICINE, 2019, 132 (06): : 749 - +